Sara Alkner
11 – 20 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
(
- Contribution to journal › Article
- 2021
-
Mark
Quality assessment of locoregional breast cancer radiotherapy in the international SENOMAC-trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical validation of a commercially available deep learning software for synthetic CT generation for brain
(
- Contribution to journal › Article
- 2020
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
MRI-only based treatment with a commercial deep-learning generation method for synthetic CT of brain
(
- Contribution to conference › Abstract
- 2019
-
Mark
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
(
- Contribution to journal › Article
-
Mark
Comparative treatment planning study for mediastinal Hodgkin’s lymphoma : impact on normal tissue dose using deep inspiration breath hold proton and photon therapy
(
- Contribution to journal › Article
-
Mark
Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
(
- Contribution to journal › Article
-
Mark
Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy
(
- Contribution to journal › Article
-
Mark
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
(
- Contribution to journal › Article